Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Dietetic-led cognitive-behavioral therapy may improve treatment for adults with ARFID.

rTMS may help treat trichotillomania in some patients.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib was generally well tolerated in children with alopecia areata.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

A gene network led by RSL4 is crucial for early root hair growth in response to cold in Arabidopsis thaliana.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.